Robert A. Harrington's Insider Trades & SAST Disclosures
Robert A. Harrington's most recent trade in Cytokinetics Inc was a trade of 324 Common Stock done at an average price of $38.6 . Disclosure was reported to the exchange on April 15, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Robert A. Harrington.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cytokinetics Inc | Robert A. Harrington | Director | Grant, award, or other acquisition of securities at price $ 38.56 per share. | 15 Apr 2025 | 324 | 14,982 (0%) | 0% | 38.6 | 12,493 | Common Stock |
| Cytokinetics Inc | Robert A. Harrington | Director | Sale of securities on an exchange or to another person at price $ 39.43 per share. | 03 Apr 2025 | 450 | 14,658 (0%) | 0% | 39.4 | 17,744 | Common Stock |
| Cytokinetics Inc | Robert A. Harrington | Director | Sale of securities on an exchange or to another person at price $ 42.50 per share. | 04 Mar 2025 | 900 | 15,108 (0%) | 0% | 42.5 | 38,250 | Common Stock |
| Cytokinetics Inc | Robert A. Harrington | Director | Grant, award, or other acquisition of securities at price $ 48.93 per share. | 02 Jan 2025 | 255 | 16,008 (0%) | 0% | 48.9 | 12,477 | Common Stock |
| Cytokinetics Inc | Robert A. Harrington | Director | Grant, award, or other acquisition of securities at price $ 52.60 per share. | 01 Oct 2024 | 237 | 15,753 (0%) | 0% | 52.6 | 12,466 | Common Stock |
| Cytokinetics Inc | Robert A. Harrington | Director | Sale of securities on an exchange or to another person at price $ 54.61 per share. | 05 Jul 2024 | 253 | 15,516 (0%) | 0% | 54.6 | 13,816 | Common Stock |
| Cytokinetics Inc | Robert A. Harrington | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 228 | 15,769 (0%) | 0% | 0 | Common Stock | |
| Cytokinetics Inc | Robert A. Harrington | Director | Sale of securities on an exchange or to another person at price $ 48.64 per share. | 03 Jun 2024 | 1,580 | 15,541 (0%) | 0% | 48.6 | 76,851 | Common Stock |
| Cytokinetics Inc | Robert A. Harrington | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 5,600 | 17,121 (0%) | 0% | 0 | Common Stock | |
| Cytokinetics Inc | Robert A. Harrington | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 3,636 | 3,636 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Cytokinetics Inc | Robert Harrington A. | Director | Grant, award, or other acquisition of securities at price $ 84.12 per share. | 02 Jan 2024 | 148 | 11,521 (0%) | 0% | 84.1 | 12,450 | Common Stock |
| Cytokinetics Inc | Robert A. Harrington | Director | Grant, award, or other acquisition of securities at price $ 33.36 per share. | 03 Jul 2023 | 374 | 10,925 (0%) | 0% | 33.4 | 12,477 | Common Stock |
| Cytokinetics Inc | Robert A. Harrington | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2023 | 10,000 | 10,000 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Cytokinetics Inc | Robert A. Harrington | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2023 | 5,000 | 10,551 (0%) | 0% | 0 | Common Stock | |
| Cytokinetics Inc | Robert A. Harrington | Director | Grant, award, or other acquisition of securities at price $ 37.71 per share. | 03 Apr 2023 | 298 | 5,551 (0%) | 0% | 37.7 | 11,238 | Common Stock |
| Cytokinetics Inc | Robert A. Harrington | Director | Grant, award, or other acquisition of securities at price $ 44.35 per share. | 03 Jan 2023 | 253 | 5,253 (0%) | 0% | 44.4 | 11,221 | Common Stock |
| Cytokinetics Inc | Robert A. Harrington | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Apr 2022 | 35,000 | 35,000 | - | - | Non-Qualified Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges